GFA
HALO icon

Godfrey Financial Associates’s Halozyme HALO Stock Holding History

Godfrey Financial Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391 Sell
5
-2
-29% -$136 ﹤0.01% 928
2026
Q1 		$452 Hold
7
– – ﹤0.01% 899
2025
Q4 		$471 Buy
+7
New +$471 ﹤0.01% 858

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Godfrey Financial Associates's HALO Position: Q2 2026 in Review

Godfrey Financial Associates reduced its Halozyme (HALO) stake by 29% in Q2 2026, selling an estimated $136 and leaving 5 shares worth $391. The position accounts for ﹤0.01% of the portfolio, ranked #928.

Godfrey Financial Associates first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. The position peaked at $471 in Q4 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Godfrey Financial Associates held 5 shares of Halozyme worth $391 as of Q2 2026.
  • Godfrey Financial Associates sold 2 Halozyme shares in Q2 2026, an estimated $136.
  • Halozyme made up ﹤0.01% of Godfrey Financial Associates's portfolio in Q2 2026, its #928 holding.
  • Godfrey Financial Associates first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • Godfrey Financial Associates's Halozyme position peaked at $471 in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.